| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.099 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |